Edinburgh Worldwide Investment Trust (EWI) Ordinary 1p
Sell:170.80p
Buy:171.40p
0
Change:
3.20p
(1.90%)
3.20p
(1.90%)
FTSE 250:0.52%
Market closed |
Prices as at close on 21 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- Create an alert
- This stock can be held in a
Sell:170.80p
Buy:171.40p
Change:
3.20p
(1.90%)
3.20p
(1.90%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Market closed |
Prices as at close on 21 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Sell:170.80p
Buy:171.40p
Change:
3.20p
(1.90%)
3.20p
(1.90%)
Market closed |
Prices as at close on 21 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
HL comment
Objective
The Company’s objective is to achieve long term capital growth by investing primarily in listed companies throughout the world. While the policy is global investment, the approach adopted is to construct a portfolio through the identification of individual companies which offer long term growth potential, normally over at least a five year horizon and which typically have a market capitalisation of less than US$5 billion at the time of initial investment.
| Security | Weight |
|---|---|
| Space Exploration Technologies Corp Series N Pref. | 6.97% |
| Alnylam Pharmaceuticals Inc | 6.02% |
| AeroVironment Inc | 4.41% |
| Oxford Nanopore Technologies Ord GBP0.001 | 3.28% |
| Space Exploration Technologies Corp Series J Pref. | 3.16% |
| Zillow Group Inc Class C | 3.11% |
| Axon Enterprise Inc | 2.96% |
| Psiquantum Series C Pref. | 2.96% |
| Exact Sciences Corp | 2.55% |
| American Superconductor Corp | 1.96% |
| Sector | Weight |
|---|---|
| Healthcare | 33.05% |
| Technology | 15.43% |
| Industrials | 11.55% |
| Communication Services | 5.01% |
| Financial Services | 3.15% |
| Consumer Cyclical | 2.02% |
| Consumer Defensive | 1.96% |
| Basic Materials | 0.72% |
| Country | Weight |
|---|---|
| United States | 52.69% |
| United Kingdom | 9.05% |
| China | 2.23% |
| Japan | 2.12% |
| Israel | 1.36% |
| Denmark | 1.15% |
| France | 0.91% |
| New Zealand | 0.85% |
| Australia | 0.68% |
| Switzerland | 0.62% |
Fee Structure
The annual management fee will be as follows 0.75% on the first GBP 50m of NAV, 0.65% on the next GBP 200m of NAV and 0.55% on the remaining NAV. The fees are calculated on a quarterly basis. The contract is terminable on 3 month notice.
Dividend Policy
The Board does not intend to draw on the revenue reserve of Company to pay or maintain dividends. The Company objective is that of generating capital growth and investors should not expect any income from this investment.
ASSET SPLIT
Trust Manager
Douglas Brodie
Manager Bio
Douglas Brodie joined Baillie Gifford in 2001 and is Head of the Discovery Team. Mr. Brodie became a Partner in 2015 and is a CFA Charterholder. He graduated BSc in Molecular Biology & Biochemistry from the University of Durham in 1997 and attained a DPhil in Molecular Immunology from the University of Oxford in 2001. Mr. Brodie has been a member of the team in 2021.
Board Of Directors
Jonathan Simpson-Dent, Jane McCracken
Data policy - All information should be used for indicative purposes only. You should
independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete,
and accepts no responsibility for how it may be used.
Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.